TNFRSF17 and plasma cell myeloma: CC-93269 (EngMab) is a humanized 2 + 1 IgG1-based T cell engager that binds to BCMA in myeloma cells and to CD3ε on T cells and has been shown to induce tumor regression in MM preclinical models [108].